FLUDEOXYGLUCOSE F-18

CHEBI:CHEBI_748069

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

brand_name_suffix
F 18
manufacturer_name
Barbara Ann Karmanos Cancer Hospital
nui
N0000000205
pharm_class_epc
Radioactive Diagnostic Agent [EPC]
pharm_class
Radiopharmaceutical Activity [MoA]
pharm_class_moa
Radiopharmaceutical Activity [MoA]
active_ingredient_name
FLUDEOXYGLUCOSE F-18
active_ingredient_strength
400 mCi/mL
unii
0Z5B2CJX4D
spl_set_id
e3791140-2e52-48c5-9849-536d5e4275e5
package_marketing_start_date
20050819
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
ANDA
dosage_form
INJECTION, SOLUTION
marketing_start_date
20111030
labeler_name
Barbara Ann Karmanos Cancer Hospital
generic_name
Fludeoxyglucose F18
brand_name
Fludeoxyglucose F18
brand_name_base
Fludeoxyglucose
product_ndc
78714-001
application_number
ANDA204385
listing_expiration_date
20241231
route
INTRAVENOUS
spl_id
6862a859-c498-4540-aade-4f982e528fbe
package_ndc
78714-001-30
package_description
30 mL in 1 VIAL, GLASS (78714-001-30)